Office-Based Buprenorphine Treatment of Opioid Use Disorder

With a new foreword by Nora Volkow, Director of the National Institute on Drug
Abuse, this second edition of Office-Based Buprenorphine Treatment of Opioid Use
Disorder provides updated information on evidence-based treatment for opioid use
disorder (OUD)-an increasingly important topic as the epidemic of opioid misuse
and overdose deaths grows in the United States.

Bulleted clinical pearls
at the end of each chapter, as well as specific clinical recommendations and
detailed case discussions throughout, make it easier for readers to retain
knowledge and integrate it into their clinical practice. The guide also features
sample documentation and scales, including a treatment contract and a patient
consent, that can be used to model documents in practice.

This new edition
of Office-Based Buprenorphine Treatment has been updated to reflect DSM-5
language, and two additional chapters have been included: one that addresses
other pharmacotherapies useful in treating OUD, including methadone and
naltrexone, and another that discusses OUD treatment specifically with regard to
women's health and pregnancy.

Among the numerous other revisions included
in the second edition are the following: Information about new formulations of
buprenorphine A discussion of the Comprehensive Addiction and Recovery Act
(CARA) Changes to induction and maintenance target doses and recommendations
for home inductions Information on diversion control plans Advice for working
with Alcoholics Anonymous and Narcotics Anonymous A discussion on integrating
buprenorphine into residential and inpatient opioid treatment programs

Written in a jargon-free style that does not require expertise in
substance use disorder treatment, Office-Based Buprenorphine Treatment of Opioid
Use Disorder is an accessible, indispensable reference for primary care
physicians, psychiatrists, nurse practitioners, residents, medical students, and
anyone with an interest in learning about and prescribing buprenorphine.